Cardiomyopathy, Hypertrophic
"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
Descriptor ID |
D002312
|
MeSH Number(s) |
C14.280.238.100 C14.280.484.150.070.160
|
Concept/Terms |
Cardiomyopathy, Hypertrophic- Cardiomyopathy, Hypertrophic
- Cardiomyopathies, Hypertrophic
- Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Cardiomyopathy, Hypertrophic Obstructive
- Cardiomyopathies, Hypertrophic Obstructive
- Hypertrophic Obstructive Cardiomyopathies
- Hypertrophic Obstructive Cardiomyopathy
- Obstructive Cardiomyopathies, Hypertrophic
- Obstructive Cardiomyopathy, Hypertrophic
Idiopathic Hypertrophic Subaortic Stenosis- Idiopathic Hypertrophic Subaortic Stenosis
- IHSS
- IHSSs
- Subvalvular Stenosis, Idiopathic Hypertrophic
- Hypertrophic Cardiomyopathy, Idiopathic
- Cardiomyopathies, Idiopathic Hypertrophic
- Cardiomyopathy, Idiopathic Hypertrophic
- Hypertrophic Cardiomyopathies, Idiopathic
- Idiopathic Hypertrophic Cardiomyopathies
- Idiopathic Hypertrophic Cardiomyopathy
- Hypertrophic Obstructive Cardiomyopathy (HOCM)
- Cardiomyopathies, Hypertrophic Obstructive (HOCM)
- Cardiomyopathy, Hypertrophic Obstructive (HOCM)
- Hypertrophic Obstructive Cardiomyopathies (HOCM)
- Idiopathic Hypertrophic Subvalvular Stenosis
- Idiopathic Hypertrophic Subaortic Stenosis (IHSS)
Asymmetric Septal Hypertrophy- Asymmetric Septal Hypertrophy
- Asymmetric Septal Hypertrophies
- Hypertrophies, Asymmetric Septal
- Hypertrophy, Asymmetric Septal
- Septal Hypertrophies, Asymmetric
- Septal Hypertrophy, Asymmetric
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in UAMS Profiles by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2024 | 1 | 0 | 1 | 2022 | 1 | 0 | 1 | 2021 | 1 | 0 | 1 | 2020 | 3 | 0 | 3 | 2019 | 1 | 0 | 1 | 2018 | 2 | 0 | 2 | 2017 | 1 | 0 | 1 | 2016 | 2 | 0 | 2 | 2015 | 2 | 1 | 3 | 2014 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2012 | 3 | 0 | 3 | 2011 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2004 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles over the past ten years.
-
Aglan A, Fath AR, Maron BJ, Maron MS, Prasad A, Almomani A, Hammadah M, Reynolds MR, Rowin EJ. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm. 2024 09; 21(9):1677-1683.
-
Subramanian M, Shekar V, Krishnamurthy P, Yalagudri S, Kaur Saggu D, Atreya AR, Chennapragada S, Narasimhan C. Optimizing diastolic filling by pacing in nonobstructive hypertrophic cardiomyopathy. Heart Rhythm. 2023 09; 20(9):1307-1313.
-
Hameed I, Siddiqui OM, Samad SA. MAVACAMTEN: A door that has opened in the treatment of Hypertrophic Cardiomyopathy. J Pak Med Assoc. 2023 02; 73(2):446-447.
-
Subramanian M, Atreya AR, Yalagudri SD, Shekar PV, Saggu DK, Narasimhan C. Catheter Ablation for Ventricular Arrhythmias in Hypertrophic Cardiomyopathy. Card Electrophysiol Clin. 2022 12; 14(4):693-699.
-
Bolin EH, Spray BJ, Mourani PM, Porter C, Collins RT. Mortality among infants of diabetic mothers with hypertrophic cardiomyopathy. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):9893-9899.
-
Gaitonde M, Jones S, McCracken C, Ferguson ME, Michelfelder E, Sachdeva R, Border W. Evaluation of Left Ventricular Outflow Gradients During Staged Exercise Stress Echocardiography Helps Differentiate Pediatric Patients With Hypertrophic Cardiomyopathy From Athletes and Normal Subjects. Pediatr Exerc Sci. 2021 07 24; 33(4):196-202.
-
Said S, Marey G. Transaortic extended left ventricular septal myectomy in an adult with hypertrophic obstructive cardiomyopathy. Multimed Man Cardiothorac Surg. 2020 12 23; 2020.
-
Said SM, Marey G, Hiremath GM. Unroofing of Myocardial Bridging After Septal Myectomy in a Child With Noonan Syndrome. World J Pediatr Congenit Heart Surg. 2021 09; 12(5):659-660.
-
Edelson JB, Griffis H, Burstein DS, Zhang X, Rossano JW, Lin KY, O'Connor MJ. The Impact of Syndromic Genetic Disorders on Medical Management and Mortality in Pediatric Hypertrophic Cardiomyopathy Patients. Pediatr Cardiol. 2020 Aug; 41(6):1180-1189.
-
Dasgupta S, Friedman H, Allen N, Stark M, Ferguson E, Sachdeva R, Border WL. Exercise stress echocardiography: Impact on clinical decision-making in pediatric patients. Echocardiography. 2019 05; 36(5):938-943.
-
St?ve SI, Blenski M, Stray-Pedersen A, Wierenga KJ, Jhangiani SN, Akdemir ZC, Crawford D, McTiernan N, Myklebust LM, Purcarin G, McNall-Knapp R, Wadley A, Belmont JW, Kim JJ, Lupski JR, Arnesen T. A novel NAA10 variant with impaired acetyltransferase activity causes developmental delay, intellectual disability, and hypertrophic cardiomyopathy. Eur J Hum Genet. 2018 09; 26(9):1294-1305.
-
O'Connor MJ, Miller K, Shaddy RE, Lin KY, Hanna BD, Ravishankar C, Rossano JW. Disopyramide use in infants and children with hypertrophic cardiomyopathy. Cardiol Young. 2018 Apr; 28(4):530-535.
-
Dasgupta S, Qasim A, Aly AM, Jain SK. Mother With Diabetes Mellitus and Infant With Hypertrophic Obstructive Cardiomyopathy: Milrinone Precluded Need for Extracorporeal Membrane Oxygenation. Circ Cardiovasc Imaging. 2017 11; 10(11).
-
Thomas TO, Knecht KR. Hypertrophic Cardiomyopathy in an Adolescent. J Ark Med Soc. 2016 Nov; 113(5):112-114.
-
Ferguson ME, Sachdeva R, Gillespie SE, Morrow G, Border W. Tissue Doppler imaging during exercise stress echocardiography demonstrates a mechanism for impaired exercise performance in children with hypertrophic cardiomyopathy. Echocardiography. 2016 Nov; 33(11):1718-1725.
-
Chaikriangkrai K, Chebrolu L, Bhatti S, Chang SM. Diagnosis of ischemia in hypertrophic cardiomyopathy: role of computed tomography and nuclear stress testing. Curr Opin Cardiol. 2015 Sep; 30(5):483-92.
-
Tang X, Cleves MA, Nick TG, Li M, MacLeod SL, Erickson SW, Li J, Shaw GM, Mosley BS, Hobbs CA. Obstructive heart defects associated with candidate genes, maternal obesity, and folic acid supplementation. Am J Med Genet A. 2015 Jun; 167(6):1231-42.
-
Lam H, Dare S, Nguyen T, Austin T. Anesthesia for a pediatric patient with cardiofaciocutaneous syndrome. A A Case Rep. 2015 Apr 01; 4(7):95-6.
-
Dai Y, Dai D, Mehta JL. MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker. J Am Coll Cardiol. 2014 Nov 18-25; 64(20):2181.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|